EMA issues recommendations on Tysabri and PML

A board to discuss the newly-released drug Tysabri, (formerly known as Antegren) as a treatment for Multiple Sclerosis
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:
Contact MSUK

EMA issues recommendations on Tysabri and PML

Post by MSUK »

European Medicines Agency issues recommendations following review of Tysabri and PML risk

The European Medicines Agency has finalised a review of Tysabri (natalizumab) and the risk of progressive multifocal leukoencephalopathy (PML), a rare brain infection caused by the JC virus................ http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1905
MS-UK - http://www.ms-uk.org/
Top
Post Reply

Return to “Tysabri (Antegren, Natalizumab)”